Fundraising FoxThynk Capital — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Klotho Therapeutics is a biotech company developing protein-based therapeutics that mimic the natural human Klotho protein to address age-related diseases including cognitive decline, kidney disease, diabetes, and cancer.
BiotechHealthtechLongevity
PartnerJim Plante· solo GP
Winsantor is a clinical-stage biotechnology company developing treatments for peripheral neuropathies, including diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy.
BiotechHealthtechMedical DevicesSan Diego, US
Stan Kim(Executive Officer, Director)inNigel Calcutt(Director)
PartnerJim Plante· solo GP
Co-investorsMethuselah Funds
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.